Search results
Results from the WOW.Com Content Network
Two concerns with applying telomerase inhibitors in cancer treatment are that effective treatment requires continuous, long-term drug application and that off-target effects are common. [30] For example, the telomerase inhibitor imetelstat, first proposed in 2003, [31] [32] has been held up in clinical trials due to hematological toxicity. [30]
If a drug can inhibit telomerase in cancer cells, the telomeres of successive generations will progressively shorten, limiting tumor growth. [56] Telomerase is a good biomarker for cancer detection because most human cancer cells express high levels of it. Telomerase activity can be identified by its catalytic protein domain .
Reflect the stage of cancer; By determining the stage of cancer, it's possible to give a prognosis and treatment plan. [3] Screening for cancers; No screening test is wholly specific, and a high level of tumor marker can still be found in benign tumors. The only tumor marker currently used in screening is PSA (prostate-specific antigen ...
90% of cancers are characterized by increased telomerase activity. [28] Lung cancer is the most well characterized type of cancer associated with telomerase. [29] There is a lack of substantial telomerase activity in some cell types such as primary human fibroblasts, which become senescent after about 30–50 population doublings. [28]
Even within subtypes of cancer cells, there exist differences in TERRA expression based on the mechanism by which cells maintain the length of their telomeres; TERRA levels have been shown to be consistently lower in telomerase positive cells compared to cells that utilize the homologous recombination-based Alternative Lengthening of Telomeres ...
To measure the concentrations of TRF1 and the relationships among telomere length, telomerase activity, and TRF1 levels in tumor and normal colorectal mucosa, from normal and tumoral samples of patients who underwent surgery for colorectal cancer we analyzed TRF1 protein concentration, and telomerase activity were analysed.
Most initial symptoms of leukemia are related to problems with the bone-marrow function. There are a variety of symptoms that children may experience. The symptoms tend to appear quickly in acute leukemia and slowly over time in chronic leukemia. [1] Symptoms in the different types of childhood leukemia include: feelings of fatigue or weakness
In patients with significant signs or symptoms, treat can involve chemotherapy, immunotherapy, or chemoimmunotherapy. [4] The most appropriate treatment is based on the individual's age, physical condition, and whether they have the del(17p) or TP53 mutation. [14] As of 2024, the recommended first-line treatments include: